How does SARS-CoV-2 wreak havoc in the body? When do antibodies appear, how long do they persist, and what is their nature? How long does the virus shed? How do common biomarker levels correlate with changing disease states and organ damage?
The MT Group has conducted dozens of longitudinal biospecimen collections over the past 20 years, offering serial patient sampling coupled with comprehensive clinical annotation, which together drive powerful disease insights as well as vaccine and therapeutic discoveries.
Our COVID-19 site network now includes dozens community clinic, hospital, and academic sites in New York, New Jersey, California, Washington, Florida, Texas, Georgia, Illinois, and other hotspots. This network depth and geographical diversity enables us to collect from specific patient populations under longitudinal collections that seek to answer important clinical questions.
Please reach out with your COVID-19 biospecimen wish lists; we look forward to exploring together how our network can accelerate your research.